Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
CHRS
#3090
Coherus Oncology, Inc. Common Stock
1.740
0
USD
+2.96%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+2.96%
Changement Mensuel
+9.43%
Evolution sur 6 mois
+8.07%
Changement Annuel
+8.07%
Clôture Précédente
1.690
0
Open
1.740
0
Bid
Ask
Low
1.740
0
High
1.740
0
Volume
40
Marchés
Actions des Marchés US
Soins de Santé
CHRS
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
115.9 M
115.93 M
116.23 M
120.87 M
149.89 M
—
Valuation ratios
Enterprise value
33.95 M
11.15 M
-131.9 M
94.88 M
123.96 M
98.09 M
Price to earnings ratio
5.52
-0.7
0.48
1.25
0.99
2.02
Price to sales ratio
0.59
0.24
0.25
0.68
3.94
5.11
Price to cash flow ratio
7.75
-108.9
1.06
2.12
1.2
-104.51
Price to book ratio
1.2
0.19
0.16
0.36
2.73
3.44
Enterprise value to EBITDA ratio
0.28
0.38
2.28
-0.99
57.18
58.84
Profitability ratios
Return on assets %
-0.22
0.15
0.68
0.07
-0.86
0.04
Return on equity %
-0.74
0.31
2.48
0.4
-3.64
-0.44
Return on invested capital %
—
—
—
—
-45.38
—
Gross margin %
55.06
65.09
66.89
67.84
68.27
268.09
Operating margin %
-17.16
597.91
443.59
383.14
359.9
1 784.54
EBITDA margin %
16.86
-606.41
-450.58
-388.89
-364.57
-1 810.45
Net margin %
-39.48
744.43
2 903.91
307.07
-1 740.22
2 215.19
Liquidity ratios
Quick ratio
0.96
1.2
1.43
1.23
1.45
5.31
Current ratio
1.21
1.22
1.44
1.24
1.47
5.37
Inventory turnover
1.9
0.07
0.85
1.13
1.55
3.6
Asset turnover
0.52
0.02
0.03
0.02
0.03
0.1
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.51
0.62
—
—
—
—
Long term debt to total equity ratio
1.73
1.25
—
—
—
—
Per share metrics
Operating cash flow per share
-0.25
0.22
0.4
0.4
0.17
1.19
EBIT per share
0.36
-0.4
-0.4
-0.39
-0.4
-1.59
EBITDA per share
0.36
-0.4
-0.4
-0.39
-0.4
-1.58
Total debt per share
—
—
—
—
—
—
Cash per share
1.1
0.71
2.05
1.65
1.47
5.88
Net current asset value per share
2.97
2.68
3.28
3.97
1.76
11.68
Tangible book value per share
0.68
1.13
0.58
0.33
0.13
2.16
Working capital per share
0.51
0.48
1
0.76
0.57
2.81
Book value per share
1.15
1.58
1.03
0.76
0.52
3.89
Nouvelles
Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year?
Coherus BioSciences à la conférence Citizens : virage stratégique vers l’oncologie
Coherus BioSciences at The Citizens Conference: Strategic Oncology Shift
Oppenheimer réitère sa recommandation Surperformance sur Coherus
Oppenheimer reiterates Coherus Biosciences stock rating at Outperform
Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call Transcript
Coherus Oncology (CHRS) Reports Q4 Loss, Misses Revenue Estimates
Le BPA de Coherus BioSciences égale les attentes, le CA en dessous des prévisions
Coherus BioSciences earnings matched, revenue fell short of estimates
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q4 Loss, Beats Revenue Estimates
Kiniksa Pharmaceuticals International, plc (KNSA) Misses Q4 Earnings Estimates
Myriad Genetics (MYGN) Q4 Earnings and Revenues Surpass Estimates